BioSpace News Archive

Research Bridge Partners—a not-for-profit that enhances the societal and economic returns on America’s investment in research universities by bridging mid-continent university innovators and commercialization resources nationally—announced the investment of seed capital in Eradivir, Inc.

Medivir AB announces that Linda Basse, Chief Medical Officer at Medivir will leave the company on September 30, 2020.

Advanced BioScience Laboratories, Inc. (ABL), a global Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) for biotherapeutics, oncolytics and vaccines, a subsidiary of the French bioindustrial group Institut Mérieux, announced today that it has completed the aseptic fill/finish of a novel COVID-19 vaccine candidate for a confidential customer.

Canada-based Airwave Electronics/Environmental, a long-time innovator in chemical gas sensing technologies, is developing a device to detect the COVID-19 virus immediately and at safe social distancing.

CovidAYACancer.org to Provide Critical Guidance to Patients and Healthcare Professionals [15-April-2020] LOS ANGELES , April 14, 2020 /PRNewswire/ -- In response to the urgent demand for expert guidance during the ongoing coronavirus pandemic, six non-profit Adolescent and Young Adult (AYA) cancer advocacy organizations have launched CovidAYACancer.org , a

Board Certified Periodontists Dr. Alexandre-Amir Aalam and Dr. Alina Krivitsky of the CENTER For Advanced Periodontal and Implant Therapy in Brentwood, Los Angeles, are the founding periodontists behind the RejuvaGum Lift™, a revolutionary procedure that uses Platelet Rich Fibrin to treat gum recession.

Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces that the Company has repriced the strike price of the 3 million stock options originally to be granted to Directors and Employees announced on March 16, 2020 to $.095 from $.075 due to recent market activity. The options will have an exercise term of five years from the date of grant. Subscribe to Lattic

Canadian biotechnology leader LuminUltra announced that it will provide 500,000 urgently needed COVID-19 tests per week to the Canadian federal government for use across Canada.

Swift Medical, SE Health, AlayaCare, Woundpedia, the University Health Network’s Michener Institute, the Mayer Institute and many others are teaming up to connect patients with wound doctors, nurses, and experts - bringing immediate telehealth relief to thousands of Canadians.

Vir Biotechnology, Inc. (NASDAQ: VIR) today announced additional interim data from the ongoing Phase 2 trial in patients and results from the Phase 1 trial in healthy volunteers of VIR-2218, an investigational small interfering ribonucleic acid (siRNA) that mediates RNA interference (RNAi) for the treatment of chronic hepatitis B virus (HBV) infection.